Barriers to new drug development in respiratory disease

Eur Respir J. 2016 Jan;47(1):356-7. doi: 10.1183/13993003.00783-2015.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Awards and Prizes
  • Diarylquinolines / therapeutic use
  • Drug Discovery*
  • Extensively Drug-Resistant Tuberculosis / drug therapy*
  • Humans
  • Motivation
  • Nitroimidazoles / therapeutic use
  • Oxazoles / therapeutic use
  • Tuberculosis, Multidrug-Resistant / drug therapy

Substances

  • Antitubercular Agents
  • Diarylquinolines
  • Nitroimidazoles
  • OPC-67683
  • Oxazoles
  • bedaquiline